Epperson T K, Patel K D, McEver R P, Cummings R D
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.
J Biol Chem. 2000 Mar 17;275(11):7839-53. doi: 10.1074/jbc.275.11.7839.
P-selectin glycoprotein ligand-1 (PSGL-1) is a disulfide-bonded, homodimeric mucin ( approximately 250 kDa) on leukocytes that binds to P-selectin on platelets and endothelial cells during the initial steps in inflammation. Because it has been proposed that only covalently dimerized PSGL-1 can bind P-selectin, we investigated the factors controlling dimerization of PSGL-1 and re-examined whether covalent dimers are required for binding its P-selectin. Recombinant forms of PSGL-1 were created in which the single extracellular Cys (Cys(320)) was replaced with either Ser (C320S-PSGL-1) or Ala (C320A-PSGL-1). Both recombinants migrated as monomeric species of approximately 120 kDa under both nonreducing and reducing conditions on SDS-polyacrylamide gel electrophoresis. P-selectin bound similarly to cells expressing either wild type or mutated forms of PSGL-1 in both flow cytometric and rolling adhesion assays. Unexpectedly, chemical cross-linking studies revealed that both C320S- and C320A-PSGL-1 noncovalently associate in the plasma membrane and cross-linking generates dimeric species. Chimeric recombinants of PSGL-1 in which the transmembrane domain in PSGL-1 was replaced with the transmembrane domain of CD43 (CD43TMD-PSGL-1) could not be chemically cross-linked, suggesting that residues within the transmembrane domain of PSGL-1 are required for noncovalent association. Cells expressing CD43TMD-PSGL-1 bound P-selectin. To further address the ability of P-selectin to bind monomeric derivatives of PSGL-1, intact HL-60 cells were trypsin-treated, which generated a soluble approximately 25-kDa NH(2)-terminal fragment of PSGL-1 that bound to immobilized P-selectin. Because N-glycosylation of PSGL-1 hinders trypsin cleavage, a recombinant form of PSGL-1 was generated in which all three potential N-glycosylation sites were mutated (DeltaN-PSGL-1). Cells expressing DeltaN-PSGL-1 bound P-selectin, and trypsin treatment of the cells generated NH(2)-terminal monomeric fragments (<10 kDa) of PSGL-1 that bound to P-selectin. These results demonstrate that Cys(320)-dependent dimerization of PSGL-1 is not required for binding to P-selectin and that a small monomeric fragment of PSGL-1 is sufficient for P-selectin recognition.
P-选择素糖蛋白配体-1(PSGL-1)是白细胞上一种通过二硫键连接的同型二聚体黏蛋白(约250 kDa),在炎症初始阶段可与血小板和内皮细胞上的P-选择素结合。由于有人提出只有共价二聚化的PSGL-1才能结合P-选择素,我们研究了控制PSGL-1二聚化的因素,并重新审视了结合其P-选择素是否需要共价二聚体。构建了重组形式的PSGL-1,其中单个细胞外半胱氨酸(Cys(320))被丝氨酸(C320S-PSGL-1)或丙氨酸(C320A-PSGL-1)取代。在SDS-聚丙烯酰胺凝胶电泳的非还原和还原条件下,两种重组体均以约120 kDa的单体形式迁移。在流式细胞术和滚动黏附试验中,P-选择素与表达野生型或突变型PSGL-1的细胞的结合情况相似。出乎意料的是,化学交联研究表明,C320S-PSGL-1和C320A-PSGL-1在质膜中均非共价缔合,交联产生二聚体形式。将PSGL-1中的跨膜结构域替换为CD43的跨膜结构域的PSGL-1嵌合重组体(CD43TMD-PSGL-1)无法进行化学交联,这表明PSGL-1跨膜结构域内的残基是非共价缔合所必需的。表达CD43TMD-PSGL-1的细胞可结合P-选择素。为了进一步研究P-选择素结合PSGL-1单体衍生物的能力,对完整的HL-60细胞进行胰蛋白酶处理,产生了一种可溶性的约25 kDa的PSGL-1 NH(2)-末端片段,该片段可与固定化的P-选择素结合。由于PSGL-1的N-糖基化会阻碍胰蛋白酶切割,构建了一种重组形式的PSGL-1,其中所有三个潜在的N-糖基化位点均发生突变(DeltaN-PSGL-1)。表达DeltaN-PSGL-1的细胞可结合P-选择素,对这些细胞进行胰蛋白酶处理会产生与P-选择素结合的PSGL-1 NH(2)-末端单体片段(<10 kDa)。这些结果表明,PSGL-1与P-选择素结合并不需要依赖Cys(320)的二聚化,并且PSGL-1的一个小单体片段足以被P-选择素识别。